PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors.

Elisabetta CavalcantiAntonia IgnazziFrancesco De Michele
Published in: Cancer biology & therapy (2018)
PDGFRα represents an effective target for new anti-angiogenic treatment in WD- GEP-NENs, in particular in G2 cases, and in G3 cases only when there is a mixed insular-acinar pattern. In this context, it is important to carefully delineate those tumors that might better respond to this type of treatment alone or in combination. Further investigation of the relationship between PD-L1 and PDGFRa is warranted, and may contribute to optimize the therapeutic approach in patients with GEP-NENs.